Tech Company Financing Transactions

Ikano Therapeutics Funding Round

Ikano Therapeutics closed a $39.1 million Series A financing round on 8/15/2006. Investors included SV Health Investors, Burrill & Company and F-Prime Capital.

Transaction Overview

Company Information

Company Status

Acquired or Merged

Industry

Biopharmaceutical

Mailing Address

250 Pehle Avenue 310
Saddle Brook, NJ 07663
USA

Phone

(201) 843-3308

Website

www.ikanotherapeutics.com

Email Address

[email protected]

Overview

Ikano Therapeutics Inc. (ITI) is a specialty pharmaceutical company focused on developing innovative specialty therapeutics, with an emphasis on drugs in areas for which there is proven, unsatisfied medical and patient need.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Peter Young

        

Chief Financial Officer

Pat Fabbio

        

Chief Medical Officer

Jeffery Edelson

        

VP - Bus. Development

Kathleen Boziwick

        

Browse more venture capital transactions:

Prev: 8/14/2006: Blurb venture capital transaction
Next: 8/15/2006: Celerus Diagnostics venture capital transaction

Share this article

Where The Data Comes From

We record every notable VC transaction. All VC database entries reported here are sourced from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary